HighTower Advisors’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
– Sell
-800
Closed -$26.4K – 3910
2025
Q3
$26.4K Buy
+800
New +$97.2K ﹤0.01% 3651

Other funds holding RGEN

HighTower Advisors's RGEN Position: Q3 2026 in Review

HighTower Advisors opened a new position in Repligen (RGEN) in Q3 2026: 1,401 shares worth $269K. The stake represents ﹤0.01% of the portfolio and ranks #3299 among its holdings. This is a return to the name: HighTower Advisors previously reported a position in RGEN as recently as Q1 2026.

HighTower Advisors first reported a position in RGEN in Q3 2017 and has held it in 36 quarters since. The position peaked at $5.15M in Q3 2021. 523 funds tracked by Wall St. Rank hold RGEN as of Q3 2026.

  • HighTower Advisors held 1,401 shares of Repligen worth $269K as of Q3 2026.
  • Repligen was a new HighTower Advisors position in Q3 2026.
  • Repligen made up ﹤0.01% of HighTower Advisors's portfolio in Q3 2026, its #3299 holding.
  • HighTower Advisors first reported a position in Repligen in Q3 2017 and has held it in 36 quarters since.
  • HighTower Advisors's Repligen position peaked at $5.15M in Q3 2021.
  • 523 funds tracked by Wall St. Rank held Repligen as of Q3 2026.

Based on HighTower Advisors's 13F filing for Q3 2026, filed 10 Nov 2026.